The international independent ranking organisation AD Scientific Index is more than an ordinary "Ranking". The "AD Scientific Index" analyses the academic work of scientists using the H-index, i10 index and number of citations, and provides results that can be used to evaluate the productivity and efficiency of individuals and institutions. In addition to ranking according to "total H-index" for individuals and institutions, you can also see the ranking and analyses according to "last 6 years H-index", "total i10 Productivity index", "last 6 years i10 Productivity index", "total citations" and "last 6 years citations" only in "AD Scientific Index". See also: Subject Rankings, University Subject Rankings and Universities Rankings 2024 (Sort by: Last 6 years H Index). Click here for individual or institutional registration.
AD Scientific Index - World Scientists Rankings - 2024 | H INDEX | i10 INDEX | CITATION | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
University / Institution |
Country | Region | World | Name | Country | University / Institution | Subject | Total | Last 6 year | Last 6 year/total | Total | Last 6 year | Last 6 year/total | Total | Last 6 year | Last 6 year/total |
8 | 13,235 | 14,641 | 31,358 |
|
United States | Genentech, Inc |
Others
|
69 | 39 | 0.565 | 139 | 88 | 0.633 | 25,817 | 8,506 | 0.329 |
9 | 14,998 | 16,622 | 36,053 |
|
United States | Genentech, Inc |
Others
Antibody therapeutics | antibody engineering | |
66 | 35 | 0.530 | 101 | 70 | 0.693 | 27,401 | 7,037 | 0.257 |
11 | 17,133 | 19,028 | 41,723 |
|
United States | Genentech, Inc |
Others
|
63 | 31 | 0.492 | 92 | 87 | 0.946 | 13,912 | 4,869 | 0.350 |
13 | 20,218 | 22,539 | 50,383 |
|
United States | Genentech, Inc |
Others
|
59 | 32 | 0.542 | 126 | 64 | 0.508 | 12,478 | 3,326 | 0.267 |
18 | 30,853 | 34,658 | 82,503 |
|
United States | Genentech, Inc |
Others
Drug Metabolism | Antibody-drug conjugate | Enzyme inhibitors | PROTAC | |
49 | 32 | 0.653 | 105 | 65 | 0.619 | 8,752 | 3,674 | 0.420 |
19 | 30,965 | 34,783 | 82,820 |
|
United States | Genentech, Inc |
Others
|
49 | 31 | 0.633 | 74 | 51 | 0.689 | 22,453 | 3,545 | 0.158 |
21 | 33,648 | 37,838 | 91,374 |
|
United States | Genentech, Inc |
Others
|
47 | 32 | 0.681 | 67 | 41 | 0.612 | 18,175 | 5,608 | 0.309 |
24 | 35,105 | 39,478 | 95,981 |
|
United States | Genentech, Inc |
Others
Host-microbe interactions | Infectious Diseases | microbiome | antibiotics | antibody | |
46 | 33 | 0.717 | 67 | 58 | 0.866 | 12,879 | 5,569 | 0.432 |
26 | 36,402 | 40,950 | 100,043 |
|
United States | Genentech, Inc |
Others
|
45 | 36 | 0.800 | 72 | 64 | 0.889 | 8,154 | 5,402 | 0.662 |
27 | 36,415 | 40,964 | 100,072 |
|
United States | Genentech, Inc |
Others
Parkinson's disease | Alzheimer's disease | Neuroscience | |
45 | 36 | 0.800 | 53 | 44 | 0.830 | 21,063 | 9,818 | 0.466 |
Click for INSTITUTIONAL BULK REGISTRATION and PREMIUM MEMBERSHIP advantages |
||||||||||||||||
28 | 36,646 | 41,237 | 100,928 |
|
United States | Genentech, Inc |
Others
|
45 | 33 | 0.733 | 56 | 51 | 0.911 | 8,205 | 3,560 | 0.434 |
29 | 37,380 | 42,115 | 103,413 |
|
United States | Genentech, Inc |
Others
mucosal immunology | physician scientist development | microbiota | |
45 | 23 | 0.511 | 84 | 44 | 0.524 | 9,284 | 1,997 | 0.215 |
32 | 40,314 | 45,465 | 113,073 |
|
United States | Genentech, Inc |
Others
|
43 | 29 | 0.674 | 71 | 52 | 0.732 | 7,601 | 4,618 | 0.608 |
41 | 52,896 | 59,791 | 156,617 |
|
United States | Genentech, Inc |
Others
Drug Discovery | Enzymology | Oncology | |
37 | 28 | 0.757 | 43 | 38 | 0.884 | 9,863 | 4,033 | 0.409 |
42 | 53,039 | 59,954 | 157,144 |
|
United States | Genentech, Inc |
Others
Ion channels | GPCRs | Drug Discovery | |
37 | 27 | 0.730 | 55 | 43 | 0.782 | 6,344 | 2,005 | 0.316 |
43 | 54,980 | 62,133 | 163,920 |
|
United States | Genentech, Inc |
Others
|
36 | 30 | 0.833 | 67 | 56 | 0.836 | 9,597 | 5,244 | 0.546 |
49 | 60,722 | 68,709 | 184,697 |
|
United States | Genentech, Inc |
Others
Translational Pathology | Oncology Biomarker Development | |
34 | 28 | 0.824 | 49 | 42 | 0.857 | 11,274 | 8,989 | 0.797 |
50 | 60,724 | 68,711 | 184,700 |
|
United States | Genentech, Inc |
Others
|
34 | 28 | 0.824 | 49 | 42 | 0.857 | 6,390 | 3,504 | 0.548 |
52 | 61,342 | 69,404 | 186,950 |
|
United States | Genentech, Inc |
Others
|
34 | 25 | 0.735 | 51 | 39 | 0.765 | 5,415 | 2,108 | 0.389 |
53 | 61,382 | 69,448 | 187,051 |
|
United States | Genentech, Inc |
Others
|
34 | 25 | 0.735 | 42 | 41 | 0.976 | 6,774 | 2,741 | 0.405 |
54 | 61,917 | 70,060 | 189,157 |
|
United States | Genentech, Inc |
Others
Vascular Biology | Cancer Biology | Cancer Immunology | |
34 | 22 | 0.647 | 50 | 37 | 0.740 | 6,589 | 1,853 | 0.281 |
55 | 62,222 | 70,411 | 190,255 |
|
United States | Genentech, Inc |
Others
|
34 | 20 | 0.588 | 56 | 35 | 0.625 | 5,942 | 2,542 | 0.428 |
58 | 63,636 | 71,981 | 195,107 |
|
United States | Genentech, Inc |
Others
Drug Discovery | |
33 | 28 | 0.848 | 56 | 48 | 0.857 | 5,427 | 2,657 | 0.490 |
59 | 64,690 | 73,205 | 199,185 |
|
United States | Genentech, Inc |
Others
Infectious diseases | microbiome | drug discovery | chemical biology | |
33 | 23 | 0.697 | 59 | 45 | 0.763 | 5,085 | 3,417 | 0.672 |
60 | 65,062 | 73,624 | 200,609 |
|
United States | Genentech, Inc |
Others
angiogenesis | vascular biology | cancer biology | oncology | |
33 | 21 | 0.636 | 67 | 40 | 0.597 | 5,213 | 2,086 | 0.400 |